TriplePoint Venture initiated with a Neutral at UBS

UBS analyst Vilas Abraham initiated coverage of TriplePoint Venture with a Neutral rating and $13.50 price target. While caution has overtaken the start-up ecosystem, there is still a unique need for venture debt, the analyst tells investors in a research note, adding that TriplePoint should remain active and fill this need. Abraham adds however that he expects a "more moderate" trajectory moving forward with about $60M in net portfolio growth vs. $200M over the last 12 months.